mr 2034 has been researched along with codeine in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (codeine) | Trials (codeine) | Recent Studies (post-2010) (codeine) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 4,815 | 730 | 952 |
| Protein | Taxonomy | mr 2034 (IC50) | codeine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 10 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 10 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.105 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gmerek, DE; Woods, JH | 1 |
1 other study(ies) available for mr 2034 and codeine
| Article | Year |
|---|---|
Substitution and primary dependence studies in animals.
Topics: Animals; Behavior, Animal; Benzomorphans; Buprenorphine; Butorphanol; Codeine; Discrimination, Psychological; Humans; Macaca mulatta; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Narcotic Antagonists; Pentazocine; Piperidines; Substance Withdrawal Syndrome | 1985 |